Obesity linked to longer survival in men with advanced melanoma
Obese patients with metastatic melanoma who are treated with targeted or immune therapies live significantly longer than those with a...
Smart bomb virus shows promise as a brain tumor...
A cold virus engineered to attack the most common and deadly of brain tumors allowed 20% of patients with recurrent glioblastoma to...
Immunotherapy leader Jim Allison honored by BBVA and King...
Organizations in Spain and Saudi Arabia recognized the leadership of Jim Allison, Ph.D., MD Anderson chair of Immunology, in...
Targeted therapies before and after surgery delay melanoma...
A pair of targeted therapies given before and after surgery for melanoma produced at least a six-fold increase in time to progression...
Checkpoint blockade immunotherapy may potentially treat...
Triple-negative breast cancer (TNBC), a highly aggressive, relapse-prone disease that accounts for one-fourth of all breast cancers,...
New study evaluates need for biopsies after breast cancer...
In an analysis of more than 120,000 women diagnosed with and treated for early-stage breast cancer, researchers from MD Anderson...